Jazz Pharmaceuticals Total Liabilities 2010-2024 | JAZZ

Jazz Pharmaceuticals total liabilities for the quarter ending December 31, 2024 were $7.919B, a 3.42% increase year-over-year.

  • Jazz Pharmaceuticals total liabilities for 2024 were $7.919B, a 3.42% increase from 2023.
  • Jazz Pharmaceuticals total liabilities for 2023 were $7.656B, a 1.2% decline from 2022.
  • Jazz Pharmaceuticals total liabilities for 2022 were $7.75B, a 7.01% decline from 2021.

Jazz Pharmaceuticals Total Liabilities 2010-2024 | JAZZ

  • Jazz Pharmaceuticals total liabilities for 2024 were $7.919B, a 3.42% increase from 2023.
  • Jazz Pharmaceuticals total liabilities for 2023 were $7.656B, a 1.2% decline from 2022.
  • Jazz Pharmaceuticals total liabilities for 2022 were $7.75B, a 7.01% decline from 2021.